<  Retour au portail Polytechnique Montréal

Documents dont l'auteur est "Jean, M."

Monter d'un niveau
Pour citer ou exporter [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Grouper par: Auteurs ou autrices | Date de publication | Sous-type de document | Aucun groupement
Nombre de documents: 9

Article de revue

Jean, M., Alamech, M., Buschmann, M. D., & Merzouki, A. (2011). Effective and safe gene-based delivery of GLP using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of diabetes. Gene Therapy, 18(8), 807-816. Lien externe

Jean, M., Smaoui, F., Lavertu, M., Methot, S., Bouhdoud, L., Buschmann, M. D., & Merzouki, A. (2009). Chitosan-Plasmid Nanoparticle Formulations for Im and Sc Delivery of Recombinant Fgf-2 and Pdgf-Bb or Generation of Antibodies. Gene Therapy, 16(9), 1097-1110. Lien externe

Communication écrite

Alameh, M., DeJesus, D., Benhamadi, M., Jean, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Chitosan nanoparticulate system for the delivery of siRNA targeting genome caretakers for the development of potential cancer therapies [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible

Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 14th Annual Meeting American Society of Gene and Cell Therapy, Seattle, WA, USA. Non disponible

Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec, Canada. Non disponible

DeJesus, D., Alameh, M., Jean, M., Lascau, V., Buschmann, M. D., & Merzouki, A. (mai 2011). Therapeutic lowering of circulating ApoB in atherosclerotic mice by intravenous administration of chitosan-siRNA nanoparticles [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible

Buschmann, M. D., Thibault, M., Merzouki, A., Lavertu, M., Ma, P. L., Jean, M., Darras, V., & Winnik, F. M. (mai 2010). Polynucleotide delivery with chitosans [Communication écrite]. 93rd Canadian Chemistry Conference, Toronto, Ontario. Non disponible

Méthot, S., Lavertu, M., Sun, J., Smaoui, F., Jean, M., Merzouki, A., & Buschmann, M. D. (septembre 2007). Efficient in vivo gene delivery using chitosan/DNA nanoparticles for applications in cartilage repair [Communication écrite]. 7th World Congress International Society for Cartilage Repair, Warsaw, Poland. Lien externe

Smaoui, F., Buschmann, M. D., Jean, M., Bouhdoud, L., Henrichon, M., Méthot, S., & Merzouki, A. (juin 2006). The chitosan used as a delivery system of therapeutic growth factors for the induction of cartilage regeneration [Communication écrite]. Canadian Society of Microbiologists Annual Conference, London, Ontario. Non disponible

Liste produite: Sun Dec 22 05:00:26 2024 EST.